share_log

Golden Matrix Group Analyst Ratings

Benzinga ·  Aug 14, 2023 04:44
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/14/2023 86.05% EF Hutton → $4 Reiterates Buy → Buy
07/18/2023 86.05% EF Hutton → $4 Reiterates Buy → Buy
06/15/2023 86.05% EF Hutton → $4 Reiterates → Buy
03/17/2023 86.05% EF Hutton → $4 Reiterates → Buy
01/19/2023 86.05% EF Hutton $3 → $4 Maintains Buy
12/22/2022 39.53% EF Hutton → $3 Initiates Coverage On → Buy

What is the target price for Golden Matrix Group (GMGI)?

The latest price target for Golden Matrix Group (NASDAQ: GMGI) was reported by EF Hutton on August 14, 2023. The analyst firm set a price target for $4.00 expecting GMGI to rise to within 12 months (a possible 86.05% upside). 6 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Golden Matrix Group (GMGI)?

The latest analyst rating for Golden Matrix Group (NASDAQ: GMGI) was provided by EF Hutton, and Golden Matrix Group reiterated their buy rating.

When is the next analyst rating going to be posted or updated for Golden Matrix Group (GMGI)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Golden Matrix Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Golden Matrix Group was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.

Is the Analyst Rating Golden Matrix Group (GMGI) correct?

While ratings are subjective and will change, the latest Golden Matrix Group (GMGI) rating was a reiterated with a price target of $0.00 to $4.00. The current price Golden Matrix Group (GMGI) is trading at is $2.15, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment